Prostate Cancer Patient Perspectives on the Use of Information in Treatment Decision-Making: A Systematic Review and Qualitative Meta-synthesis.

Q1 Medicine
Ontario Health Technology Assessment Series Pub Date : 2017-05-01 eCollection Date: 2017-01-01
Sujane Kandasamy, Ahmad Firas Khalid, Umair Majid, Meredith Vanstone
{"title":"Prostate Cancer Patient Perspectives on the Use of Information in Treatment Decision-Making: A Systematic Review and Qualitative Meta-synthesis.","authors":"Sujane Kandasamy, Ahmad Firas Khalid, Umair Majid, Meredith Vanstone","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Men with low- to intermediate-risk prostate cancer are typically asked to choose from a variety of treatment options, including active surveillance, radical prostatectomy, or brachytherapy. The Prolaris cell cycle progression test is intended to provide additional information on personal risk status to assist men with prostate cancer in their choice of treatment. To assist with assessing that new technology, this report synthesizes qualitative research on how men with prostate cancer use information to make decisions about treatment options.</p><p><strong>Methods: </strong>We performed a systematic review and qualitative meta-synthesis to retrieve and synthesize findings across primary qualitative studies that report on patient perspectives during prostate cancer treatment decision-making.</p><p><strong>Results: </strong>Of 8,610 titles and abstracts reviewed, 29 studies are included in this report. Most men diagnosed with prostate cancer express that their information-seeking pathway extends beyond the medical information received from their health care provider. They access other social resources to attain additional medical information, lived-experience information, and medical administrative information to help support their final treatment decision. Men value privacy, trust, honesty, control, power, organization, and open communication during interactions with their health care providers. They also emphasize the importance of gaining comfort with their treatment choice, having a chance to confirm their health care provider's recommendations (validation of treatment plan), and exercising their preferred level of independence in the treatment decision-making process.</p><p><strong>Conclusions: </strong>Although each prostate cancer patient is unique, studies suggest that most patients seek extensive information to help inform their treatment decisions. This may happen before, during, and after the treatment choice is made. Given the amount of information patients may access, it is important that they also establish the trustworthiness of the various types and sources of information. When information conflicts, patients may be unsure about how to proceed. Open collaboration between patients and their health care providers can help patients manage and navigate their concerns so that their values and perspectives are captured in their treatment choices.</p>","PeriodicalId":39160,"journal":{"name":"Ontario Health Technology Assessment Series","volume":"17 7","pages":"1-32"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451209/pdf/ohtas-17-1.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ontario Health Technology Assessment Series","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Men with low- to intermediate-risk prostate cancer are typically asked to choose from a variety of treatment options, including active surveillance, radical prostatectomy, or brachytherapy. The Prolaris cell cycle progression test is intended to provide additional information on personal risk status to assist men with prostate cancer in their choice of treatment. To assist with assessing that new technology, this report synthesizes qualitative research on how men with prostate cancer use information to make decisions about treatment options.

Methods: We performed a systematic review and qualitative meta-synthesis to retrieve and synthesize findings across primary qualitative studies that report on patient perspectives during prostate cancer treatment decision-making.

Results: Of 8,610 titles and abstracts reviewed, 29 studies are included in this report. Most men diagnosed with prostate cancer express that their information-seeking pathway extends beyond the medical information received from their health care provider. They access other social resources to attain additional medical information, lived-experience information, and medical administrative information to help support their final treatment decision. Men value privacy, trust, honesty, control, power, organization, and open communication during interactions with their health care providers. They also emphasize the importance of gaining comfort with their treatment choice, having a chance to confirm their health care provider's recommendations (validation of treatment plan), and exercising their preferred level of independence in the treatment decision-making process.

Conclusions: Although each prostate cancer patient is unique, studies suggest that most patients seek extensive information to help inform their treatment decisions. This may happen before, during, and after the treatment choice is made. Given the amount of information patients may access, it is important that they also establish the trustworthiness of the various types and sources of information. When information conflicts, patients may be unsure about how to proceed. Open collaboration between patients and their health care providers can help patients manage and navigate their concerns so that their values and perspectives are captured in their treatment choices.

Abstract Image

Abstract Image

前列腺癌患者对治疗决策中信息使用的看法:系统回顾与定性元综合》。
背景:患有中低风险前列腺癌的男性通常会被要求从各种治疗方案中做出选择,包括积极监测、根治性前列腺切除术或近距离放射治疗。Prolaris 细胞周期进展测试旨在提供有关个人风险状况的额外信息,以帮助前列腺癌男性患者选择治疗方案。为了帮助评估这项新技术,本报告综合了有关前列腺癌男性患者如何利用信息来决定治疗方案的定性研究:我们进行了一项系统性综述和定性荟萃,以检索和综合报告前列腺癌治疗决策过程中患者观点的主要定性研究结果:结果:在查阅的8610篇标题和摘要中,有29项研究被纳入本报告。大多数被诊断出患有前列腺癌的男性患者表示,他们寻求信息的途径不仅仅局限于从医疗服务提供者那里获得医疗信息。他们会利用其他社会资源来获取更多的医疗信息、生活经验信息和医疗管理信息,以帮助他们做出最终的治疗决定。在与医疗服务提供者的互动中,男性重视隐私、信任、诚实、控制、权力、组织和开放式交流。他们还强调,在治疗选择上获得舒适感、有机会确认医疗服务提供者的建议(治疗计划的验证)以及在治疗决策过程中行使他们所希望的独立程度,这些都非常重要:尽管每位前列腺癌患者都是独一无二的,但研究表明,大多数患者都会寻求广泛的信息来帮助他们做出治疗决定。这可能发生在治疗选择之前、期间和之后。考虑到患者可能获取的信息量,重要的是他们还要确定各类信息和信息来源的可信度。当信息发生冲突时,患者可能不知道如何继续治疗。患者与医疗服务提供者之间的坦诚合作可以帮助患者处理和解决他们所关心的问题,从而在治疗选择中体现他们的价值观和观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ontario Health Technology Assessment Series
Ontario Health Technology Assessment Series Medicine-Medicine (miscellaneous)
CiteScore
4.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信